Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: CalciMedica Inc., 3 years.
CalciMedica Inc.
Director
Lantheus Holdings Inc.
Director
Zentalis Pharmaceuticals Inc.
Director · CEO & President
Chief executive roles
Zentalis Pharmaceuticals Inc.
· CEO & President
Since November 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 2025 | Lantheus Holdings Inc. | Grant or award | +2,537 | — | — |
| Feb 3, 2025 | Zentalis Pharmaceuticals Inc. | Grant or award | +59,388 | — | — |
| Jan 31, 2025 | Zentalis Pharmaceuticals Inc. | Open-market purchase | +28,500 | $1.73 | $49,305 |
| Sep 10, 2024 | Lantheus Holdings Inc. | Grant or award | +1,345 | — | — |
| Mar 23, 2023 | CalciMedica Inc. | Sold back to the company | +1,429 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.